Enzyme behind immune cell response revealed

October 12, 2017, Monash University
L-R: Dr Simona Infantino, Mr Nick Kocovski, Mr Michael Low, Prof David Tarlinton. Credit: Monash university

Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body. Moreover, they suggest that the enzyme may be a potential target for drug development to block the types of inappropriate or excessive cell behaviour that occur in cancer and autoimmunity.

The production of antibodies - proteins secreted into our blood that neutralise invaders such as bacteria and viruses - is one of the immune system's most important ways of protecting us from infections.

But the that ultimately make or secrete the antibody - a type of white blood cell called B-cells or B-lymphocytes - need to change significantly to do this. They have to be activated, proliferate and change their function, all of which requires significant remodeling of the machinery of the cell.

Researchers from Monash's Central Clinical School led by Professor David Tarlinton, Head of the Immune Memory Laboratory, discovered that an enzyme called PRMT1 is behind this remodeling.

"The cumulative effect of PRMT1 activity in B cells is to make the cells able to sustain the cell division and differentiation that is required to make antibodies," Professor Tarlinton said.

"Without PRMT1 in B cells, there is no antibody production and no way to clear an infection."

The study was published today in Nature Communications. First author is Dr Simona Infantino.

The study observed in mice models, an increase in the amount of the enzyme and in its activity - and then observed this in human B cells in a petri dish.

"I think we have very good reason to think and expect that the properties we see in mouse B cells will be repeated in if stimulated in the same way," Professor Tarlinton said.

He said the enzyme had many targets that have previously been identified and found to be important for particular processes, but that it had not been known previously that PRMT1 was required for a complete immune cell response.

"The is a potential target in the future for blocking this behaviour when it is inappropriate, such as when cells divide and multiply in cancer. It's probably also important for lymphocytes in auto-immune disease," he said. "Any time that you want to suppress immune responses, this would provide an opportunity or a druggable target."

However, such drugs would have many side-effects, he cautioned.

Professor Tarlinton said that preliminary data indicated that the process may be a feature of the way all respond to dramatic changes in their environment.

Explore further: Researchers show how a protein prevents the uncontrolled expansion of immune cells

More information: Simona Infantino et al, Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation, Nature Communications (2017). DOI: 10.1038/s41467-017-01009-1

Related Stories

Researchers show how a protein prevents the uncontrolled expansion of immune cells

June 22, 2017
The mammalian immune system consists of millions of individual cells that are produced daily from precursor cells in the bone marrow. During their development, immune cells undergo a rapid expansion, which is interrupted ...

Researchers makes 'natural born killer' cell discovery

August 31, 2017
An unexpected role for a white blood cell called the Natural Killer (NK) cell - a critical cell for ridding the body of infection and cancer, has been discovered by researchers at New Zealand's University of Otago.

New type of blood cells work as indicators of autoimmunity

August 14, 2017
A team from Instituto de Medicina Molecular Lisboa, led by Luis Graça, has analyzed blood samples from patients with Sjögren syndrome, an autoimmune disease that affects the mucous membranes and moisture-secreting glands ...

Immune cells may be key to better allergy, infection therapies

July 28, 2017
By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell research.

Scientists discover an essential mechanism in the immune response

July 5, 2017
Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have discovered that the transcriptional regulator CTCF plays an essential role in antibody production. The study, led by Dr. Almudena ...

Immune cell 'survival' gene key to better myeloma treatments

February 3, 2013
Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune ...

Recommended for you

Doctors may be able to enlist a mysterious enzyme to stop internal bleeding

August 14, 2018
Blood platelets are like the sand bags of the body. Got a cut? Platelets pile in to clog the hole and stop the bleeding.

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

Researchers artificially generate immune cells integral to creating cancer vaccines

August 14, 2018
For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

The medicine of the future against infection and inflammation?

August 13, 2018
Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances ...

During HIV infection, antibody can block B cells from fighting pathogens

August 13, 2018
For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 (IgG3) stops the immune system's B cells from doing their normal job of fighting pathogens. This ...

Link between common 'harmless' virus and cardiovascular damage

August 13, 2018
Researchers from Brighton and Sussex Medical School (BSMS) have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.